Home › Schizophrenia › Connecticut › New Haven
Schizophrenia clinical trials in New Haven, CT
6 studies for Schizophrenia are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
RecruitingPhase 3
- Local Institution - 0154, New Haven
A Study of Brenipatide in Adult Participants With Schizophrenia
RecruitingPhase 2
- Yale University School of Medicine, New Haven
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
RecruitingPhase 1Healthy volunteers welcome
- West Haven Veterans Affairs Medical Center, West Haven · 3 mi away
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
RecruitingObservational studyHealthy volunteers welcome
- Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven
SV2 PET Imaging With [11C]APP311
RecruitingObservational studyHealthy volunteers welcome
- Conneticut Mental Health Center, New Haven
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
RecruitingPhase 2/3
- Yale School of Medicine, New Haven
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Little Rock, AR19 studies
- Hollywood, FL15 studies
- Boston, MA14 studies
- Houston, TX13 studies
- San Diego, CA13 studies
- New York City, NY13 studies
- Hialeah, FL13 studies
- Austin, TX13 studies
- Garden Grove, CA12 studies
- Germantown, MD11 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Opioid Overdose18 studies
- Alcohol Use Disorder (AUD)17 studies
- Acute Myeloid Leukemia17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.